Elevance Health, Inc.
Elevance Health
ELV · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $199.1B
- Assets
- $121.5B
- SEC filing
- DEF 14A
- Filed
- March 27, 2026
Executive Compensation
Compensation reported for Elevance Health’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Gail Boudreaux
President And Chief Executive Officer (ceo)
$22.6M
Reported total
- Salary
- $1,600,000
- Stock awards
- $13,440,277
- Incentives
- $2,768,000
- Option awards
- $4,199,765
- Other
- $574,272
Mark Kaye
EVP and Chief Financial Officer (CFO)
$8M
Reported total
- Salary
- $938,462
- Stock awards
- $4,560,511
- Incentives
- $974,123
- Option awards
- $1,424,506
- Other
- $94,475
Peter Haytaian
EVP and President, Carelon and Carelon Rx
$7.1M
Reported total
- Salary
- $950,000
- Stock awards
- $3,840,306
- Incentives
- $986,100
- Option awards
- $1,199,710
- Other
- $122,372
Felicia Norwood
EVP and Chief Health Benefits Officer
$7.1M
Reported total
- Salary
- $950,000
- Stock awards
- $3,840,306
- Incentives
- $986,100
- Option awards
- $1,199,710
- Other
- $97,849
Morgan Kendrick
Evp And President, Commercial And Specialty Health Benefits
$6.7M
Reported total
- Salary
- $888,462
- Stock awards
- $3,600,237
- Incentives
- $922,223
- Option awards
- $1,124,813
- Other
- $126,176
Gail Boudreaux
President And Chief Executive Officer (ceo)
$22.6M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed March 27, 2026.
- Salary
- $1.6M
- Stock Awards
- $13.4M
- Option Awards
- $4.2M
- Incentives
- $2.8M
- Other
- $574K
Historical Compensation
Gail Boudreaux total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,600,000 | $13,440,277 | $22,582,314 |
| 2024 | $1,600,000 | $12,600,032 | $20,471,976 |
| 2023 | $1,600,000 | $11,850,043 | $21,889,039 |
Named Executive Officers
Gail Boudreaux
President And Chief Executive Officer (ceo)
Elevance Health · ELV
$22.6M
FY 2025 · DEF 14A
Mark Kaye
EVP and Chief Financial Officer (CFO)
Elevance Health · ELV
$8M
FY 2025 · DEF 14A
Peter Haytaian
EVP and President, Carelon and Carelon Rx
Elevance Health · ELV
$7.1M
FY 2025 · DEF 14A
Felicia Norwood
EVP and Chief Health Benefits Officer
Elevance Health · ELV
$7.1M
FY 2025 · DEF 14A
Morgan Kendrick
Evp And President, Commercial And Specialty Health Benefits
Elevance Health · ELV
$6.7M
FY 2025 · DEF 14A
Source information
- Company
- Elevance Health, Inc.
- Ticker
- ELV · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- March 27, 2026
- SEC accession number
- 0001156039-26-000031
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company →
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company →
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company →
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company →